Zaremba Rabourn Amy (CIK 1832343) reported 7 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-04-27). Recent activity: Sell IRD (1,641 shares), Sell IRD (2,816 shares), Buy IRD (86,500 shares), Sell IRD (3,390 shares), Sell IRD (3,950 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-04-27 | Opus Genetics, Inc. (IRD) | Head of Fin. Quality Assurance | Sell | 1,641 | $8,540 |
| 2026-03-18 | Opus Genetics, Inc. (IRD) | Head of Fin. Quality Assurance | Sell | 2,816 | $14,784 |
| 2026-01-26 | Opus Genetics, Inc. (IRD) | Head of Fin. Quality Assurance | Buy | 86,500 | $0 |
| 2026-01-21 | Opus Genetics, Inc. (IRD) | Head of Fin. Quality Assurance | Sell | 3,390 | $7,119 |
| 2026-01-13 | Opus Genetics, Inc. (IRD) | Head of Fin. Quality Assurance | Sell | 3,950 | $7,624 |
| 2025-03-17 | Opus Genetics, Inc. (IRD) | SVP of Finance | Buy | 39,500 | $0 |
| 2025-02-06 | Opus Genetics, Inc. (IRD) | SVP of Finance | Sell | 8,190 | $9,337 |
Source: SEC Form 4 filings · as of 2026-04-27